Scaled Speech Fluency & Botulinum Toxin in Neurogenic Inflammation - Essay Sample

Introduction

The primary purpose of this article and the study in it was to study the connection of scaled speech fluency and the particular acoustic variables in individuals with dysarthria (First, 2019). In other words, the research in the article was intended to identify how small amounts of botulinum toxin in combination with other peptides would be applied in the control and regulation of the neurogenic inflammatory disorders. Speakers and control speakers with Parkinson's disease (PD) and amyotrophic lateral sclerosis were used for the production of sentences which were later analyzed perceptually and acoustically (First, 2019). Acoustic variables were made of the total utterance durations, approximations of acoustic vowel space, segment duration and formant transition slopes. The perceptual variables being measured in the study were scaled speech fluency as well as speech participation severity. The subjects were the speakers and control speakers, and they played a very crucial role in the study.

Is your time best spent reading someone else’s essay? Get a 100% original essay FROM A CERTIFIED WRITER!

Save 25%

Interventions/Methods, Outcome Measures

The speech of the various subjects in the study was used to collect then required information about inflammatory disorders and the outcomes used to come up with a conclusion whether the neurogenic disorders had affected the speakers and if the application of the botulinum toxic with other peptides will change the speech-language pathology of these speakers. The outcome was measured by the various variables listed above to identify the speech-language pathology level of each speaker.

Results

The results of the study showed that temporal variables made a difference between the ALS groups, unlike the PD group. From controls and vowel spaces being smaller for the two neurogenic groups, the temporal variables were significant only to the ASL speakers (First, 2019). As a result, there is a complicated connection amongst acoustic measures and scaled speech fluency. More results showed that composite results are determined and discussed based on single word versus sentence intelligibility estimates as well as their acoustic bases.

Conclusions, Comments/Impressions

This journal article and the study discussed in it is an excellent way to help improve the future of speech-language pathology because it provides information on the methods and variables which can be used to identify issues in speech-language pathology in different speakers. The variables affecting ASL speakers are not the same as those of PD speakers, and thus with information from this article, it will be easy to understand each of the two groups of speakers. In the application of the botulinum toxic and other peptides, the impact will be different in the two different groups. Still, the final result will be an improvement of the spoken language of the speakers. This study is informing about the measures which can be taken in the future to help deal with and correct issues of speech in neurogenic inflammatory disorder affected persons. It has got crucial information on how well the neurogenic problems can be controlled with peptides and botulinum toxic to correct the disorders and make the speech pathology of the speaker improve gradually.

First, E. R. (2019). U.S. Patent No. 6,063,768. Washington, DC: U.S. Patent and Trademark Office